Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 8929 [2021-02688]

Download as PDF Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices The DG, entitled, ‘‘Safety-Related Steel Structures and Steel-Plate Composite Walls for other than Reactor Vessels and Containments’’ is a proposed new guide temporarily identified by its task number, DG–1304. It proposes guidance to meet regulatory requirements for safety-related steel structures and steel-plate composite walls for other than reactor vessels and containments. It endorses with, exceptions and clarifications, the 2018 edition of ANSI/AISC N690–2018, ‘‘Specification for Safety-Related Steel Structures for Nuclear Facilities.’’ The staff is also issuing for public comment a draft regulatory analysis (ADAMS Accession No. ML20339A559). The staff develops a regulatory analysis to assess the value of issuing or revising a regulatory guide as well as alternative courses of action. III. Backfitting, Forward Fitting, and Issue Finality Issuance of DG–1304, if finalized, would not constitute backfitting as that term is defined in title 10 of the Code of Federal Regulations (10 CFR) section 50.109, ‘‘Backfitting,’’ and as described in NRC Management Directive 8.4, ‘‘Management of Backfitting, Forward Fitting, Issue Finality, and Information Requests’’; constitute forward fitting as that term is defined and described in MD 8.4; or affect issue finality of any approval issued under 10 CFR part 52, ‘‘Licenses, Certificates, and Approvals for Nuclear Power Plants.’’ As explained in DG–1304, applicants and licensees are not required to comply with the positions set forth in DG–1361. Dated: February 4, 2021. For the Nuclear Regulatory Commission. Meraj Rahimi, Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2021–02720 Filed 2–9–21; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 16, 2021. A sample of agenda items to be discussed during the public session includes: An overview of fiscal SUMMARY: VerDate Sep<11>2014 18:53 Feb 09, 2021 Jkt 253001 year 2020 medical related events; a discussion on the status of the NRC’s patient release evaluation of emerging brachytherapy sources; a discussion on calibration procedures for existing and emerging brachytherapy sources; a discussion on the current ACMUI reporting structure; and an overview on the consequences of radiopharmaceutical extravasation and therapeutic interventions in nuclear medicine. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI’s Meetings and Related Documents web page at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html or by emailing Ms. Kellee Jamerson at the contact information below. DATES: Date and Time for Open Session: Tuesday, March 16, 2021, from 10:00 a.m. to 3:45 p.m. EST. ADDRESSES: Date March 16, 2021. Webinar information Link: https:// usnrc.webex.com. Event number: 199 910 9533. Public Participation: Due to the ongoing COVID–19 public health emergency, the meeting will be held as a webinar using Cisco WebEx. Any member of the public who wishes to participate in any portion of this meeting should register in advance of the meeting by accessing the provided link above. Upon successful registration, a confirmation email will be generated providing the telephone bridge line and a link to join the webinar on the day of the meeting. Members of the public should also monitor the NRC’s Public Meeting Schedule at https:// www.nrc.gov/pmns/mtg for any meeting updates. If there are any questions regarding the meeting, persons should contact Ms. Jamerson using the information below. FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: 301–415–7408. SUPPLEMENTARY INFORMATION: Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Conduct of the Meeting The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 8929 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by the close of business on March 10, 2021 and must only pertain to the topics on the agenda. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2021.html on or about May 3, 2021. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned participation. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, Part 7. Dated at Rockville, Maryland this 4th day of February, 2021. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2021–02688 Filed 2–9–21; 8:45 am] BILLING CODE 7590–01–P OFFICE OF PERSONNEL MANAGEMENT Submission for Review: 3206–0156, Application for Death Benefits Under the Civil Service Retirement System (SF 2800); Documentation in Support of Application for Death Benefits When Deceased Was an Employee at the Time of Death (CSRS) Office of Personnel Management. ACTION: 60-Day notice and request for comments. AGENCY: Retirement Services, Office of Personnel Management (OPM) offers the general public and other federal agencies the opportunity to comment on a renewal with minor edits of information collection request (ICR), SF 2800—Application for Death Benefits (CSRS) and SF 2800A—Documentation and Elections in Support of Application for Death Benefits When Deceased Was an Employee at the Time of Death (CSRS). We have updated the way we display the OMB control number and there are editorial changes to the SUMMARY: E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 86, Number 26 (Wednesday, February 10, 2021)]
[Notices]
[Page 8929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02688]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on March 16, 2021. A sample of agenda items to be discussed 
during the public session includes: An overview of fiscal year 2020 
medical related events; a discussion on the status of the NRC's patient 
release evaluation of emerging brachytherapy sources; a discussion on 
calibration procedures for existing and emerging brachytherapy sources; 
a discussion on the current ACMUI reporting structure; and an overview 
on the consequences of radiopharmaceutical extravasation and 
therapeutic interventions in nuclear medicine. The agenda is subject to 
change. The current agenda and any updates will be available on the 
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Ms. 
Kellee Jamerson at the contact information below.

DATES: Date and Time for Open Session: Tuesday, March 16, 2021, from 
10:00 a.m. to 3:45 p.m. EST.

ADDRESSES: 

------------------------------------------------------------------------
                   Date                          Webinar information
------------------------------------------------------------------------
March 16, 2021............................  Link: https://usnrc.webex.com.
                                            Event number: 199 910 9533.
------------------------------------------------------------------------

    Public Participation: Due to the ongoing COVID-19 public health 
emergency, the meeting will be held as a webinar using Cisco WebEx. Any 
member of the public who wishes to participate in any portion of this 
meeting should register in advance of the meeting by accessing the 
provided link above. Upon successful registration, a confirmation email 
will be generated providing the telephone bridge line and a link to 
join the webinar on the day of the meeting. Members of the public 
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any 
questions regarding the meeting, persons should contact Ms. Jamerson 
using the information below.

FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: 
[email protected], telephone: 301-415-7408.

SUPPLEMENTARY INFORMATION: 
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.

Conduct of the Meeting

    The ACMUI Chair, Darlene F. Metter, M.D., will preside over the 
meeting. Dr. Metter will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson using the contact information listed 
above. All submittals must be received by the close of business on 
March 10, 2021 and must only pertain to the topics on the agenda.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about May 3, 2021.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
participation.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland this 4th day of February, 2021.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-02688 Filed 2-9-21; 8:45 am]
BILLING CODE 7590-01-P